🇺🇸 FDA
Pipeline program

POHIM-RT

SMC 2017-03-092-002

Unknown other active

Quick answer

POHIM-RT for Cervix Cancer is a Unknown program (other) at Samsung Bioepis NL B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Samsung Bioepis NL B.V.
Indication
Cervix Cancer
Phase
Unknown
Modality
other
Status
active

Clinical trials